Recombinant immune complexes (rICs) as a therapeutic for Multiple Sclerosis (MS): effect on myeloid cell activationJin Wang, Elizabeth Fitzpatrick, Danehy Caroline Margaret et al.|The Journal of Immunology|2023Cited by 0